The FDA granted 510(k) clearance to the first automated robotic movement software designed for Corindus Vascular Robotics (OTC:CVRS) CorPath GRX percutaneous coronary intervention platform, the company reported today. The Rotate on Retract feature allows the person operating the CorPath GRX to navigate to a targeted lesion by automatically turning the guidewire upon joystick retraction. The software […]
Corindus Vascular Robotics
Corindus wins FDA 510(k) PVI indication for CorPath GRX
Corindus Vascular Robotics (OTC:CVRS) said today it won FDA 510(k) clearance for its CorPath GRX system, now indicated for use in peripheral vascular interventions. The Waltham, Mass.-based company touts the CorPath system as the first and only FDA-cleared robotic device cleared for both percutaneous coronary interventions and peripheral vascular interventions. “My colleagues and I have seen first-hand […]
Corindus partners with Medtronic on interventional cardiology courses, releases prelim Q4, 2017 earnings
Corindus Vascular Robotics (OTC:CVRS) yesterday said it will co-sponsor training courses with medical giant Medtronic (NYSE:MDT) on transradial access techniques and robot-assisted vascular interventions, and released preliminary earnings results for its fourth quarter and fiscal year 2017. The Waltham, Mass.-based company said it plans to help sponsor courses designed to train for operations using robotic-assisted percutaneous coronary interventions using […]
Corindus joins with Mayo Clinic in study of tele-robotic stenting
Corindus Vascular Robotics (OTC:CVRS) said today it is working with the Mayo Clinic to launch preclinical studies exploring the use of telestenting, a robotic treatment for percutaneous coronary interventions which can be operated by physicians in remote locations. The Waltham, Mass.-based surgical robotics company said that there is a global shortage of PCI-capable operators, and that telestenting […]
Corindus touts 1st Corpath GRX system installation outside the US
Corindus Vascular Robotics (OTC:CVRS) today touted the first commercial installation of its CorPath GRx robotic surgical system outside of the US. The CorPath GRX platform, a robot-assisted system for percutaneous coronary interventions such as stenting, was purchased and installed at the Ahmedabad, India’s Apex Heart Institute, the Waltham, Mass.-based company said. Read the whole story on […]
Corindus Vascular Robotics to test-drive HeartFlow’s 3D cardiac imaging tech
Corindus Vascular Robotics (OTC:CVRS), a Massachusetts-based surgical robotics company, plans to utilize technology that creates 3D images of arteries for evaluating patients. Company officials said they’d employ California-based HeartFlow’s FFRct Analysis in a case series of robotic-assisted percutaneous coronary interventions to evaluate the technology’s role in clinical decision support. The testing will be done at hospitals […]
Corindus opens first international training center for CorPath GRX System
Corindus Vasular Robotics opened its first international CorPath GRX Robotic Center in Tokyo to educate cardiologists on robotic-assisted percutaneous coronary interventions, the company announced today. “The opening of the first international robotic center represents an important milestone in the process of bringing precision vascular robotics to patients and physicians in Japan and around the world,” […]
Corindus launches post-approval study for CorPath GRX robot-assisted PCI
Corindus Vascular Robotics (OTC:CVRS) announced the first patient enrollment in a post-market study of its second-generation CorPath GRX System, a robot-assisted system for percutaneous coronary interventions such as stenting. “Enrollment of the first patient in the Precision GRX registry is a major milestone for the company and we look forward to the participation of leading centers […]
Corindus Vascular Robotics shares dip despite Q2 beat
Shares in Corindus Vascular Robotics (NYSE:CVRS) have fallen today despite the surgical robotics developer posting 2nd quarter earnings which topped Wall Street expectations. The Waltham, Mass.-based company posted losses of $8.4 million, or 4¢ per share, on sales of $2.3 million for the 3 months ended June 30, seeing losses grow 10.8% while sales grew a […]
Robotic surgery: Here’s everything you need to know
[<a href=”//storify.com/MedTechDaily/getting-started” target=”_blank”>View the story “Robotic surgery: Here’s everything you need to know” on Storify</a>]
Corindus touts high success rate in CorPath 200 PCI registry study
Corindus Vascular Robotics (NYSE:CVRS) released post-market findings from the Precision registry study of its CorPath 200 system used during percutaneous coronary interventions, touting high clinical and technical success rates. Data from the registry study was presented at the 2017 Society for Cardiovascular Angiography and Interventions Scientific Sessions last Friday, the Waltham, Mass.-based company said. The Precision […]